Inflarx Nv Stock Analysis
| IFRX Stock | USD 0.88 0.03 3.53% |
IPO Date 8th of November 2017 | 200 Day MA 1.1398 | 50 Day MA 1.005 | Beta 1.503 |
InflaRx NV holds a debt-to-equity ratio of 0.015. At this time, InflaRx NV's Debt To Equity is fairly stable compared to the past year. Debt Equity Ratio is likely to rise to 0.01 in 2026, whereas Short and Long Term Debt Total is likely to drop slightly above 688.3 K in 2026. With a high degree of financial leverage come high-interest payments, which usually reduce InflaRx NV's Earnings Per Share (EPS).
Asset vs Debt
Equity vs Debt
InflaRx NV's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. InflaRx NV's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps InflaRx Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect InflaRx NV's stakeholders.
For many companies, including InflaRx NV, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for InflaRx NV, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, InflaRx NV's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Price Book 1.0696 | Enterprise Value Ebitda 0.5036 | Price Sales 947.3322 | Shares Float 55.5 M | Wall Street Target Price 10.4385 |
Given that InflaRx NV's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which InflaRx NV is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of InflaRx NV to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, InflaRx NV is said to be less leveraged. If creditors hold a majority of InflaRx NV's assets, the Company is said to be highly leveraged.
At this time, InflaRx NV's Total Stockholder Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 104.5 M in 2026, whereas Common Stock Total Equity is likely to drop slightly above 2.3 M in 2026. . At this time, InflaRx NV's Price To Sales Ratio is fairly stable compared to the past year. Price Book Value Ratio is likely to rise to 2.16 in 2026, whereas Price Earnings Ratio is likely to drop (2.88) in 2026. InflaRx NV is undervalued with Real Value of 3.25 and Target Price of 10.44. The main objective of InflaRx NV stock analysis is to determine its intrinsic value, which is an estimate of what InflaRx NV is worth, separate from its market price. There are two main types of InflaRx NV's stock analysis: fundamental analysis and technical analysis.
The InflaRx NV stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. InflaRx NV is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day ( substitute day ), Independence Day. InflaRx Stock trading window is adjusted to America/New York timezone.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in InflaRx NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. InflaRx Stock Analysis Notes
About 30.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 1.07. Some equities with similar Price to Book (P/B) outperform the market in the long run. InflaRx NV recorded a loss per share of 0.74. The entity had not issued any dividends in recent years. InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. InflaRx N.V. was founded in 2007 and is headquartered in Jena, Germany. Fireman BV is traded on NASDAQ Exchange in the United States. To learn more about InflaRx NV call Prof MD at 49 3641 508 180 or check out https://www.inflarx.de.InflaRx NV Investment Alerts
| InflaRx NV generated a negative expected return over the last 90 days | |
| InflaRx NV has some characteristics of a very speculative penny stock | |
| InflaRx NV has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 165.79 K. Net Loss for the year was (46.06 M) with loss before overhead, payroll, taxes, and interest of (5.17 M). | |
| InflaRx NV currently holds about 23.68 M in cash with (48.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.54. | |
| InflaRx NV has a poor financial position based on the latest SEC disclosures | |
| Latest headline from simplywall.st: Heres Why Were A Bit Worried About InflaRxs Cash Burn Situation |
InflaRx Largest EPS Surprises
Earnings surprises can significantly impact InflaRx NV's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-10-30 | 2025-09-30 | -0.1511 | -0.18 | -0.0289 | 19 | ||
2025-08-07 | 2025-06-30 | -0.1729 | -0.21 | -0.0371 | 21 | ||
2025-05-07 | 2025-03-31 | -0.17 | -0.13 | 0.04 | 23 |
InflaRx Stock Institutional Investors
| Shares | Squarepoint Ops Llc | 2025-06-30 | 146 K | Commonwealth Equity Services Inc | 2025-06-30 | 144 K | Virtu Financial Llc | 2025-06-30 | 60.4 K | Gsa Capital Partners Llp | 2025-06-30 | 58 K | Birchview Capital, Lp | 2025-06-30 | 50 K | Geode Capital Management, Llc | 2025-06-30 | 43.7 K | Hrt Financial Llc | 2025-06-30 | 43.5 K | Simplex Trading, Llc | 2025-06-30 | 25.7 K | Cibc World Markets Inc. | 2025-06-30 | 25 K | Suvretta Capital Management, Llc | 2025-06-30 | 6.5 M | 683 Capital Management Llc | 2025-06-30 | 2.5 M |
InflaRx Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 59.53 M.InflaRx Profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.55) | (0.57) | |
| Return On Capital Employed | (0.99) | (1.03) | |
| Return On Assets | (0.55) | (0.57) | |
| Return On Equity | (0.86) | (0.82) |
Management Efficiency
InflaRx NV has return on total asset (ROA) of (0.4069) % which means that it has lost $0.4069 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7249) %, meaning that it created substantial loss on money invested by shareholders. InflaRx NV's management efficiency ratios could be used to measure how well InflaRx NV manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.57 in 2026. Return On Capital Employed is likely to drop to -1.03 in 2026. At this time, InflaRx NV's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 6.1 M in 2026, whereas Net Tangible Assets are likely to drop slightly above 81.2 M in 2026.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.94 | 0.89 | |
| Tangible Book Value Per Share | 0.94 | 0.89 | |
| Enterprise Value Over EBITDA | (2.43) | (2.55) | |
| Price Book Value Ratio | 2.06 | 2.16 | |
| Enterprise Value Multiple | (2.43) | (2.55) | |
| Price Fair Value | 2.06 | 2.16 | |
| Enterprise Value | 141.4 M | 254.5 M |
The strategic initiatives led by InflaRx NV's management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Technical Drivers
As of the 19th of February, InflaRx NV retains the Standard Deviation of 5.17, market risk adjusted performance of (0.32), and Risk Adjusted Performance of (0.09). InflaRx NV technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.InflaRx NV Price Movement Analysis
The output start index for this execution was twenty-nine with a total number of output elements of thirty-two.
InflaRx NV Outstanding Bonds
InflaRx NV issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. InflaRx NV uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most InflaRx bonds can be classified according to their maturity, which is the date when InflaRx NV has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
InflaRx NV Predictive Daily Indicators
InflaRx NV intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of InflaRx NV stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
InflaRx NV Forecast Models
InflaRx NV's time-series forecasting models are one of many InflaRx NV's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary InflaRx NV's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.InflaRx NV Bond Ratings
InflaRx NV financial ratings play a critical role in determining how much InflaRx NV have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for InflaRx NV's borrowing costs.| Piotroski F Score | 4 | Poor | View |
| Beneish M Score | (3.30) | Unlikely Manipulator | View |
InflaRx NV Debt to Cash Allocation
As InflaRx NV follows its natural business cycle, the capital allocation decisions will not magically go away. InflaRx NV's decision-makers have to determine if most of the cash flows will be poured back into or reinvested in the business, reserved for other projects beyond operational needs, or paid back to stakeholders and investors.
InflaRx NV currently holds 805.09 K in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest the company is not taking enough advantage from borrowing. InflaRx NV has a current ratio of 9.73, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about InflaRx NV's use of debt, we should always consider it together with its cash and equity.InflaRx NV Total Assets Over Time
InflaRx NV Assets Financed by Debt
The debt-to-assets ratio shows the degree to which InflaRx NV uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.InflaRx NV Debt Ratio | 1.16 |
InflaRx NV Corporate Bonds Issued
InflaRx Short Long Term Debt Total
Short Long Term Debt Total |
|
About InflaRx Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how InflaRx NV prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling InflaRx shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as InflaRx NV. By using and applying InflaRx Stock analysis, traders can create a robust methodology for identifying InflaRx entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (319.49) | (335.47) | |
| Operating Profit Margin | (367.70) | (386.08) | |
| Net Loss | (319.53) | (335.50) | |
| Gross Profit Margin | (21.86) | (20.77) |
Current InflaRx Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. InflaRx analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. InflaRx analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Target Price | Consensus | # of Analysts | |
| 10.44 | Strong Buy | 7 | Odds |
Most InflaRx analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand InflaRx stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of InflaRx NV, talking to its executives and customers, or listening to InflaRx conference calls.
InflaRx Stock Analysis Indicators
InflaRx NV stock analysis indicators help investors evaluate how InflaRx NV stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading InflaRx NV shares will generate the highest return on investment. By understating and applying InflaRx NV stock analysis, traders can identify InflaRx NV position entry and exit signals to maximize returns.
| Begin Period Cash Flow | 12.8 M | |
| Common Stock Shares Outstanding | 58.9 M | |
| Total Stockholder Equity | 61.4 M | |
| Total Cashflows From Investing Activities | 52.4 M | |
| Tax Provision | 5217.00 | |
| Property Plant And Equipment Net | 1 M | |
| Cash And Short Term Investments | 18.4 M | |
| Cash | 18.4 M | |
| Accounts Payable | 3.4 M | |
| Net Debt | -17.6 M | |
| 50 Day M A | 1.005 | |
| Total Current Liabilities | 14.2 M | |
| Other Operating Expenses | 53.2 M | |
| Non Current Assets Total | 4.4 M | |
| Non Currrent Assets Other | 247.8 K | |
| Stock Based Compensation | 4.1 M |
Additional Tools for InflaRx Stock Analysis
When running InflaRx NV's price analysis, check to measure InflaRx NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InflaRx NV is operating at the current time. Most of InflaRx NV's value examination focuses on studying past and present price action to predict the probability of InflaRx NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InflaRx NV's price. Additionally, you may evaluate how the addition of InflaRx NV to your portfolios can decrease your overall portfolio volatility.